The end of cancer treatment is a time of transition. For many patients, survivorship care plans ease the move into post-treatment life.
Memorial Sloan Kettering investigator Ann Zauber answers questions about the risks and benefits of colon cancer screening in the elderly.
A study shows that treatment of severe combined immunodeficiency (SCID) with stem cell transplantation is very effective, especially if done early.
View highlights from the opening ceremony of the Fifth World Congress of the International Federation of Head and Neck Oncologic Societies, which included opening remarks from Bill Clinton and a keynote speech from Michael Douglas.
Today, we spotlight our dermatology nurses. Learn more about them.
In this Q&A and video, medical oncologist Mark Dickson discusses his approach to treating sarcoma and melanoma and how he develops individual treatment plans for each patient.
Memorial Sloan Kettering has ranked as a “best hospital” for cancer care for the past 25 years, according to U.S. News & World Report, and appears at number one on the 2014–15 list.
In this Q&A, medical oncologist William Tap describes Memorial Sloan Kettering’s expertise in providing cutting-edge treatment for people with different types of soft tissue sarcoma.
Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it.
Register to attend a live webinar on breast reconstruction featuring MSK plastic surgeon Andrea Pusic.